Prof. Dr. Rita Schmutzler - Curriculum Vitae
Education and Professional Career
since 2019: Director of the National Center for Familial Tumors (NCFT) at the Center of Integrated Oncology (CIO) of the University Hospital Cologne
since 2012: Director of the Center for Familial Breast and Ovarian Cancer, University of Cologne
since 2005: Coordinator of the German Consortium Hereditary Breast and Ovarian Cancer
since 2003: Full professor at the Dept. Ob/Gyn (C3), Div. Molecular Gynaeco-Oncology, University of Cologne and Head of the Center for Familial Breast and Ovarian Cancer at the University of Cologne
since 1997: Head of the Centre for Familial Breast and Ovarian Cancer at the University Cologne and Bonn; supported by German Cancer Aid
1994 - 1997: “Habilitation” fellowship of the DFG at the University of Bonn
1997: Postdoctoral lecturing qualification (Habilitation), University of Bonn, Cancer at the Women's Hospital of the University of Bonn
since 1994: Head of multiple third-party funded projects on the identification and diagnostic, preventive and therapeutic significance of breast cancer-associated risk genes by
1989 - 1990: DFG scholarship on Gene Variants of the Estrogen Receptor in Breast Cancer, Mount Sinai Medical School, New York, USA
1989 - 1991: Fellowship of the German Research Community (Deutsche Forschungsgemeinschaft, DFG) in Molecular Oncology at Mount Sinai Hospital New York, USA
1989: Practical training course in molecular biology at the EMBL, Heidelberg
1988: Federal Licensing Examination (FLEX), USA
1986 - 1992: Advanced training in gynecology and obstetrics at the University of Bonn
1985 - 1992: Resident in Ob/Gyn, University Womens Hospital of Bonn
1984: Foreign Medical Graduate Examination in the Medical Sciences (FMGEMS), USA
1984 - 1985: Fellowship of the German Academic Exchange Service (DAAD) in Reproductive Medicine at the Eastern Virginia Medical School, Norfolk, VA, USA
1979 - 1984: Medical School and Doctorate, University of Bonn
Awards, distinctions and professional activities
2023: German Prize for Cancer Prevention Research
2021: Innovation Award of the State of North Rhine-Westphalia
2021: University Award 2020 in the category "Research”
since 2021: Member of the steering committee genomDE, pilot project to establish a nationwide platform for medical genome sequencing, funded by the BMG
since 2021: Member of the Senate of the Helmholtz Association
since 2020: Member of the committee of experts of the German Cancer Aid (Deutsche Krebshilfe, DKH)
since 2020: member of the board of TMF, Technology and Methods Platform for Networked Medical Care e.V., umbrella organization for collaborative medical research in Germany, funded by the BMBF
2020: German Cancer Award 2020 (translational part) of the German Cancer Society and the German Cancer Foundation
since 2018: Congress President of PerMediCon (Personalized Medicine Convention, the congress fair for personalized medicine, Cologne)
since 2017: Expert of the S3 guideline commissions for endometrial carcinoma of the German Society for Gynecology and Obstetrics and the German Cancer Society
since 2017: Permanent Guest on the Scientific Advisory Board of the Federal Ministry of Health (BMG)
since 2017: Member and Vice-Chairwoman of the Scientific Advisory Board of the Federal Institute for Drugs and Medical Devices (BfArM)
since 2016: Member of the scientific advisory board of the State Cancer Registry (Landeskrebsregister Nordrhein-Westfalen)
2015 - 2023: Member of the scientific advisory board of the Institute for Quality and Efficiency in Health Care (IQWIG)
since 2013: Member of the Scientific Advisory Board of the Cancer Information Service (KID) of the German Cancer Research Center (DKFZ)
since 2012: Founding member of the Adolphe Monkiedje Foundation for the Promotion of Students at the University of Yaounde, Cameroon
since 2012: Member of the ethics committee of the “National Cohort“ supported by the BMBF
2012 - 2017: Member of the ethics committee of the Biobank of the RWTH Aachen supported by the German Federal Ministry of Education and Research (BMBF)
2011 - 2016: Head of the working group on hereditary tumors (Arbeitsgemeinschaft für erbliche Tumorerkrankungen, AET) of the German Cancer Society (Deutsche Krebsgesellschaft, DKG)
since 2011: Member of the steering committee of the National Cancer Plan
2010-2013: Member of the Central Ethics Commission at the German Medical Association
2010 - 2012: Elected board member of the DGGG
since 2010: Founding member of the patient advocacy group for persons at risk for breast and ovarian cancer (www.BRCA-netzwerk.de)
2010: Gunther-Bastert-Innovation Award of the DGGG
since 2009: Expert of the German Society for Gynecology and Obstetrics (DGGG) in the Genetic Diagnostics Commission at the Robert Koch Institute Berlin for the German Society for Gynecology and Obstetrics
since 2009: Member of the expert panel for the National Cancer Plan and responsible for the paper on risk-adapted early detection in Field of Action 1
2008 - 2016: Member of the committee of experts (Fachkollegiat) of the DFG
2008 - 2012: Member of the German National Cancer Plan, Speaker of the paper “Risk-adjusted Cancer Screening"
since 2007: Expert of the S3 guideline commissions for early detection of breast cancer and for the diagnosis, therapy and aftercare of breast cancer of the German Society for Gynecology and Obstetrics and the German Cancer Society
since 2005: Speaker of the German Consortium for Hereditary Breast- and Ovarian Cancer
2004 - 2013: Member of the committee of experts of the “Deutsche Krebshilfe”, DKH
1999: Ingrid-zu-Solms Award of the „Deutscher Ärztinnenbund“, DÄB
1998: Walter-Hohlweg Award of the DGGG
1991: Research Award: „Niederrheinisch-Westf. Gesellschaft für Gynäkologie und Geburtshilfe“
1989: Research Award: „Deutsche Gesellschaft für Gynäkologie und Geburtshilfe“, DGGG